Latest Regulatory Framework News

Riedel Resources Limited has progressed its Kingman Project in Arizona, securing $1.4 million in fresh capital to fund drilling and development activities at the high-grade Tintic deposit. The company also strengthened its board with the appointment of an experienced independent director.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

Ramelius Resources has officially withdrawn its conditional takeover bid for Spartan Resources following court approval of a competing scheme of arrangement, setting the stage for Spartan’s shares to be acquired under the scheme.

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Infinity Lithium progresses its Australian gold-copper-silver exploration with new option agreements, while facing delays and strategic shifts in its Spanish lithium project.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

Bio-Gene Technology Limited has completed the second tranche of its share placement, securing approximately A$2.46 million and issuing unlisted options to investors and its lead manager.

MIXI Australia Pty Ltd has initiated an all-cash off-market takeover bid for PointsBet Holdings Limited at $1.20 per share, a significant premium recommended unanimously by the PointsBet Board. The offer promises certainty of cash consideration amid competing bids and regulatory conditions.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Australian Bond Exchange Holdings has joined a Reserve Bank of Australia-led pilot exploring atomic settlement of tokenised bonds using digital currencies, aiming to transform bond market infrastructure.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.